ALK(SZ:002940) Xin Lang Cai Jing·2025-09-12 09:01Group 1 - The core viewpoint of the news is that Anglikon has seen a significant increase in its stock price, rising by 5.01% to reach 43.39 yuan per share, with a trading volume of 448 million yuan and a turnover rate of 5.72%, resulting in a total market capitalization of 8.753 billion yuan [1] - Anglikon Pharmaceutical Co., Ltd. is located in Shengzhou, Zhejiang Province, and was established on December 30, 2001. It was listed on October 23, 2018. The company's main business involves the research, production, and sales of chemical raw materials and formulations [1] - The revenue composition of Anglikon is as follows: formulations account for 43.46%, raw materials 39.82%, specialty intermediates 12.44%, others 3.72%, and pharmaceutical excipients 0.56% [1] Group 2 - From the perspective of fund holdings, Huafu Fund has a significant position in Anglikon, with its Huafu Health and Entertainment Flexible Allocation Mixed A Fund (001563) holding 150,000 shares, representing 7.52% of the fund's net value, making it the second-largest holding [2] - The Huafu Health and Entertainment Flexible Allocation Mixed A Fund was established on August 4, 2015, with a latest scale of 33.8496 million yuan. Year-to-date returns are 63.49%, ranking 389 out of 8174 in its category; the one-year return is 66.3%, ranking 1688 out of 7981; and since inception, the return is 58.19% [2] - The fund manager of Huafu Health and Entertainment Flexible Allocation Mixed A Fund is Liao Qingyang, who has been in the position for 3 years and 308 days, with a total asset scale of 74.027 million yuan. The best fund return during his tenure is 42.84%, while the worst is -0.06% [2]